Tag: essential thrombocythemia

JAK2 and TET2 mutations temporally linked with myeloproliferative disorder outcomes

Momelotinib reduces symptom burden compared to danazol in patients with myelofibrosis

byJessie Willisand1 others

February 8, 2023

1. After a 24-week treatment period, a significantly greater proportion of patients randomized to momelotinib had symptom scores reduced by ...

#VisualAbstract Higher risk of mortality during COVID-19 infection among patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib at COVID-19 diagnosis

byKathleen Lau

January 29, 2021

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result